Company / Total Assets
ANAPTYSBIO, INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$364.4M
FY2025
5-year range
$364.4M / $643.1M
FY2021-FY2025
Trend
-24.7%
vs FY2024
Sector context
#165 of 214
Health Care
What the data says
ANAPTYSBIO, INC's total assets of $364M is lower than 77% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 10 years, ranging from $62M in FY2016 to $643M in FY2021.
Based on SEC 10-K filings.
$364M in FY2025 with a 5-year CAGR of -2.6%.
Declined from $452M to $364M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -15.8%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 214This company $364.4M Sector average $7.5B
▼
-95.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.6%, indicating a declining trend.
- In FY2025, total assets decreased 24.7% year-over-year.
- Ranks #165 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $364.4M | -24.7% |
| FY2024 | $483.8M | +7.0% |
| FY2023 | $452.4M | -25.9% |
| FY2022 | $610.4M | -5.1% |
| FY2021 | $643.1M | +54.4% |
| FY2020 | $416.6M | -4.3% |
| FY2019 | $435.2M | -14.5% |
| FY2018 | $509.0M | +54.5% |
| FY2017 | $329.4M | +429.7% |
| FY2016 | $62.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026